AMN: financial statements from SEC — TradeAlmanac

AMN

AMN Healthcare Services Inc: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	2.73bn	2.98bn
Cost of revenue	1.96bn	2.06bn
Gross profit	774m	919m
Selling, general and administrative	593m	632m
Operating expenses	830m	1.02bn
Operating income	−55m	−103m
Income tax	−5m	−26m
Net income	−96m	−147m
Earnings per share	−2.48	−3.85
Earnings per share, diluted	−2.48	−3.85
Weighted average shares	39m	38m
Weighted average shares, diluted	39m	38m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	561m	34m	53m	42m	56m	11m	111m	126m
Receivables	395m	383m	391m

Cash flow

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	269m	320m
Depreciation and amortisation	157m	174m
Share-based compensation	31m	23m
Capital expenditure	36m	81m
Investing cash flow	4m	−80m
Share buybacks	0

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)